Ipamorelin/CJC-1295 mix 5 mg + 5 mg (preorder)

53.50€

3 Products -5%

50.82 € /pc

6 Products -10%

48.15 € /pc

8 Products -15%

45.48 € /pc

Third-Party Tested

Laboratory test for this product

View the certificate of analysis and laboratory verification for this product.

View laboratory test

Ipamorelin / CJC 1295 Blend 10 mg (5 mg + 5 mg) research-grade lyophilized peptide powder in a glass vial. This blend combines the selective ghrelin receptor agonist Ipamorelin with CJC-1295 (no DAC, Mod GRF 1-29), a Growth Hormone Releasing Hormone (GHRH) analog, studied in experimental models of pituitary function and growth hormone (GH) secretion dynamics.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

Purity

High-purity research grade

Form

Lyophilized peptide powder

Content

5 mg Ipamorelin & 5 mg CJC-1295 (no DAC) per vial

Packaging

Glass vial with sterile closure

Storage

Store lyophilized at 2–8 °C (desiccated, protect from light)

Molecular formula

Mixture

Molecular weight

Mixture

Sequences

Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
CJC-1295 (no DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

CAS numbers

170851-70-4 (Ipamorelin)
863288-34-0 (CJC-1295 no DAC)

In laboratory workflows, lyophilized research peptides are typically handled with suitable sterile diluents such as bacteriostatic water (BAC). For a compatible research-only solvent, see Bacteriostatic water – 10 ml .

Research Overview

The Ipamorelin / CJC-1295 (no DAC) Blend 10 mg (5 mg + 5 mg) combines two complementary growth hormone secretagogues: Ipamorelin, a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R), and CJC-1295 (no DAC), a modified GHRH analog (Mod GRF 1-29). In experimental endocrinology, this dual-agonist blend is used as a tool compound to investigate GH/IGF-1 axis regulation, pituitary signaling and pulsatile growth hormone secretion patterns in in vitro and in vivo research models.

Primary Research Areas

Growth hormone secretion dynamics: Laboratory models exploring synergistic GH release via concurrent activation of GHS-R by Ipamorelin and GHRH receptors by CJC-1295 (no DAC), including studies of GH pulse amplitude and frequency.
Pituitary and hypothalamic signaling: Experiments evaluating downstream intracellular pathways in pituitary somatotrophs and hypothalamic circuits in response to combined ghrelin receptor and GHRH receptor stimulation.
GH/IGF-1 axis modulation: Preclinical research assessing how the blend influences growth hormone and insulin-like growth factor 1 (IGF-1) patterns in controlled endocrine models, without implying any therapeutic or performance outcomes.
Endocrine feedback and receptor interactions: Studies focused on feedback regulation, receptor desensitization and cross-talk between ghrelin, GHRH and somatostatin pathways under dual-secretagogue stimulation.
Method development and assay calibration: Use of the Ipamorelin / CJC-1295 blend as a reference tool in assay development, bioanalytical method validation and mechanistic GH secretion research in vitro and in vivo.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.